Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
45
pubmed:dateCreated
2009-11-11
pubmed:abstractText
Regulatory T cells (Tregs) can suppress a wide range of immune cells, making them an ideal candidate for the treatment of autoimmunity. The potential clinical translation of targeted therapy with antigen-specific Tregs is hampered by the difficulties of isolating rare specificities from the natural polyclonal T cell repertoire. Moreover, the initiating antigen is often unknown in autoimmune disease. Here we tested the ability of antigen-specific Tregs generated by retroviral gene transfer to ameliorate arthritis through linked suppression and therefore without cognate recognition of the disease-initiating antigen. We explored two distinct strategies: T cell receptor (TCR) gene transfer into purified CD4+CD25+ T cells was used to redirect the specificity of naturally occurring Tregs; and co-transfer of FoxP3 and TCR genes served to convert conventional CD4(+) T cells into antigen-specific regulators. Following adoptive transfer into recipient mice, the gene-modified T cells engrafted efficiently and retained TCR and FoxP3 expression. Using an established arthritis model, we demonstrate antigen-driven accumulation of the gene modified T cells at the site of joint inflammation, which resulted in a local reduction in the number of inflammatory Th17 cells and a significant decrease in arthritic bone destruction. Together, we describe a robust strategy to rapidly generate antigen-specific regulatory T cells capable of highly targeted inhibition of tissue damage in the absence of systemic immune suppression. This opens the possibility to target Tregs to tissue-specific antigens for the treatment of autoimmune tissue damage without the knowledge of the disease-causing autoantigens recognized by pathogenic T cells.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-10323452, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-10899917, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-11067961, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-11812990, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-12522256, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-12612578, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-14530324, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-14634133, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15184499, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15591438, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15931392, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15972960, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16473830, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16772372, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16818678, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16917003, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17114489, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17130300, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17210729, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17220874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17440104, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17620361, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17878367, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17984976, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18024188, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18066074, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18490709, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18617638, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18809613, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18846251, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19036923, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19050237, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19350586, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19955436, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-7636184, http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-9885918
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19078-83
pubmed:dateRevised
2010-9-28
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.
pubmed:affiliation
Department of Immunology, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't